US Patent Issued to SANGAMO THERAPEUTICS on Dec. 30 for "Controlled transgene expression in regulatory t cells" (California Inventor)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,703, issued on Dec. 30, was assigned to SANGAMO THERAPEUTICS INC. (Richmond, Calif.).

"Controlled transgene expression in regulatory t cells" was invented by Anthony Conway (Emeryville, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides mammalian cells such as regulatory T cells containing a transgene in the FOXP3 genomic locus. Also provided are methods of generating the cells and methods of using the cells to treat patients in need of immunosuppression."

The patent was filed on May 21, 2020, under Application No. 16/880,402.

*For further information, including images, charts and tables, please visit: http://pat...